Douglas Lane & Associates, LLC Novo Nordisk A S Transaction History

Douglas Lane & Associates, LLC

  • $6.89 Billion
  • Q2 2024

A detailed history of Douglas Lane & Associates, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Douglas Lane & Associates, LLC holds 4,805 shares of NVO stock, worth $658,285. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,805
Previous 4,742 1.33%
Holding current value
$658,285
Previous $608,000 12.66%
% of portfolio
0.01%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 08, 2024
BUY
$122.71 - $146.91 $7,730 - $9,255
63 Added 1.33%
4,805 $685,000
Q4 2023

Jan 17, 2024
SELL
$87.78 - $105.45 $17,556 - $21,090
-200 Reduced 4.05%
4,742 $490,000
Q3 2023

Oct 16, 2023
BUY
$90.94 - $199.54 $220,165 - $483,086
2,421 Added 96.03%
4,942 $449,000
Q1 2023

Apr 17, 2023
SELL
$132.34 - $159.14 $6,087 - $7,320
-46 Reduced 1.79%
2,521 $401,000
Q4 2022

Jan 17, 2023
SELL
$102.55 - $135.33 $69,631 - $91,889
-679 Reduced 20.92%
2,567 $347,000
Q3 2022

Oct 14, 2022
SELL
$95.28 - $116.93 $14,292 - $17,539
-150 Reduced 4.42%
3,246 $323,000
Q1 2022

Apr 25, 2022
SELL
$93.1 - $112.54 $3,072 - $3,713
-33 Reduced 0.96%
3,396 $377,000
Q4 2021

Jan 25, 2022
SELL
$95.88 - $117.08 $7,191 - $8,781
-75 Reduced 2.14%
3,429 $384,000
Q2 2021

Jul 19, 2021
SELL
$67.66 - $84.76 $23,681 - $29,666
-350 Reduced 9.08%
3,504 $294,000
Q1 2021

Apr 19, 2021
SELL
$67.06 - $75.82 $3,353 - $3,790
-50 Reduced 1.28%
3,854 $260,000
Q4 2020

Jan 14, 2021
BUY
$63.89 - $73.8 $3,194 - $3,690
50 Added 1.3%
3,904 $273,000
Q3 2020

Oct 19, 2020
SELL
$63.69 - $70.22 $11,782 - $12,990
-185 Reduced 4.58%
3,854 $268,000
Q2 2020

Jul 28, 2020
BUY
$58.54 - $67.94 $31,026 - $36,008
530 Added 15.1%
4,039 $264,000
Q1 2020

Apr 20, 2020
SELL
$49.46 - $64.78 $153,375 - $200,882
-3,101 Reduced 46.91%
3,509 $211,000
Q4 2019

Jan 27, 2020
BUY
$49.86 - $58.26 $10,470 - $12,234
210 Added 3.28%
6,610 $383,000
Q2 2019

Jul 08, 2019
SELL
$46.79 - $52.47 $84,362 - $94,603
-1,803 Reduced 21.98%
6,400 $327,000
Q4 2018

Jan 17, 2019
BUY
$41.54 - $47.25 $340,752 - $387,591
8,203 New
8,203 $378,000
Q4 2017

Jan 24, 2018
SELL
$47.53 - $53.73 $349,583 - $395,184
-7,355 Closed
0 $0
Q3 2017

Oct 19, 2017
BUY
$41.15 - $49.22 $302,658 - $362,013
7,355
7,355 $354,000

Others Institutions Holding NVO

# of Institutions
1,990
Shares Held
318M
Call Options Held
5.23M
Put Options Held
4.97M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $309B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Douglas Lane & Associates, LLC Portfolio

Follow Douglas Lane & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Douglas Lane & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Douglas Lane & Associates, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email